Literature DB >> 1636656

The escalating problem of antimicrobial resistance in Streptococcus pneumoniae.

P J Chesney.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1636656     DOI： 10.1001/archpedi.1992.02160200034022

Source DB:  PubMed          Journal:  Am J Dis Child        ISSN： 0002-922X


× No keyword cloud information.
  18 in total

1.  Pharmacodynamics of glycopeptides in the mouse peritonitis model of Streptococcus pneumoniae or Staphylococcus aureus infection.

Authors:  J D Knudsen; K Fuursted; S Raber; F Espersen; N Frimodt-Moller
Journal:  Antimicrob Agents Chemother       Date:  2000-05       Impact factor: 5.191

2.  Invasive Streptococcus pneumoniae infections: serotype distribution and antimicrobial resistance in Canada, 1992-1995.

Authors:  M Lovgren; J S Spika; J A Talbot
Journal:  CMAJ       Date:  1998-02-10       Impact factor: 8.262

3.  Serious infections due to penicillin-resistant Streptococcus peneumoniae in two children with nephrotic syndrome.

Authors:  M Ilyas; S Roy; S Abbasi; R J Leggiadro; B K English; R J Wyatt
Journal:  Pediatr Nephrol       Date:  1996-10       Impact factor: 3.714

4.  Development of interpretive criteria and quality control limits for macrolide and clindamycin susceptibility testing of Streptococcus pneumoniae.

Authors:  J H Jorgensen; J M Swenson; F C Tenover; A Barry; M J Ferraro; P R Murray; L B Reller
Journal:  J Clin Microbiol       Date:  1996-11       Impact factor: 5.948

5.  In vivo activity and pharmacodynamics of cefotaxime or ceftriaxone in combination with fosfomycin in fibrin clots infected with highly penicillin-resistant Streptococcus pneumoniae.

Authors:  P Chavanet; H Beloeil; A Pechinot; F Duigou; J C Buisson; M Duong; C Neuwirth; A Kazmierczak; H Portier
Journal:  Antimicrob Agents Chemother       Date:  1995-08       Impact factor: 5.191

6.  Development of interpretive criteria and quality control limits for broth microdilution and disk diffusion antimicrobial susceptibility testing of Streptococcus pneumoniae.

Authors:  J H Jorgensen; J M Swenson; F C Tenover; M J Ferraro; J A Hindler; P R Murray
Journal:  J Clin Microbiol       Date:  1994-10       Impact factor: 5.948

7.  Pneumococcal resistance to antimicrobial agents in the province of Québec, Canada.

Authors:  L P Jetté; L Ringuette; A Dascal; J R Lapointe; P Turgeon
Journal:  J Clin Microbiol       Date:  1994-10       Impact factor: 5.948

8.  Relationship of MICs to efficacy of cefotaxime in treatment of Streptococcus pneumoniae infections.

Authors:  R F Jacobs; S L Kaplan; G E Schutze; A S Dajani; R J Leggiadro; C S Rim; S K Puri
Journal:  Antimicrob Agents Chemother       Date:  1996-04       Impact factor: 5.191

9.  Effect of dexamethasone on therapy of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis.

Authors:  M M París; S M Hickey; M I Uscher; S Shelton; K D Olsen; G H McCracken
Journal:  Antimicrob Agents Chemother       Date:  1994-06       Impact factor: 5.191

10.  Efficacy of clarithromycin treatment of acute otitis media caused by infection with penicillin-susceptible, -intermediate, and -resistant Streptococcus pneumoniae in the chinchilla.

Authors:  C M Alper; W J Doyle; J T Seroky; C D Bluestone
Journal:  Antimicrob Agents Chemother       Date:  1996-08       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.